# A Novel Treatment For Chronic Posttraumatic Stress Disorder (PTSD) Using Post-Reactivation Propranolol

> **NCT01127568** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Douglas Mental Health University Institute** · enrollment: 50 (estimated)

## Conditions studied

- Stress Disorders, Post-Traumatic

## Interventions

- **DRUG:** Propranolol is available in generic form as the Wyeth product under the trade name Inderal.

## Key facts

- **NCT ID:** NCT01127568
- **Lead sponsor:** Douglas Mental Health University Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-02
- **Primary completion:** 2010-09
- **Final completion:** 2012-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2010-05-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01127568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01127568, "A Novel Treatment For Chronic Posttraumatic Stress Disorder (PTSD) Using Post-Reactivation Propranolol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01127568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*